Propofol β-D-glucuronide

• Description:

  Propofol β-D-glucuronide is a metabolite of Propofol sulfate and can be used for diagnosis to distinguish colorectal cancer from healthy individuals[1].

• Product Name Alternative:

  NVP-AEE 788

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/propofol-β-d-glucuronide.html

• Purity:

  99.55

• Solubility:

  DMF : 30 mg/mL (ultrasonic; warming) |DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  CC(C1=CC=CC(C(C)C)=C1O[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)C(O)=O)C

• Molecular Formula:

  C18H26O7

• Molecular Weight:

  354.39

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Tangtang, et al. Marker combination for diagnosing advanced colorectal tumor, and application thereof. Patent WO2023185709A1

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, sealed storage, away from moisture)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [114991-26-3]